These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35139221)

  • 1. Kynurenine pathway of tryptophan metabolism in patients with familial Mediterranean fever.
    Tezcan D; Onmaz DE; Sivrikaya A; Körez MK; Hakbilen S; Gülcemal S; Yılmaz S
    Mod Rheumatol; 2023 Mar; 33(2):398-407. PubMed ID: 35139221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired kynurenine metabolism in patients with primary Sjögren's syndrome.
    Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sak F; Humeyra Yerlikaya F; Yilmaz S; Abusoglu G; Kazim Korez M; Unlu A
    Clin Biochem; 2023 Apr; 114():1-10. PubMed ID: 36681140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of kynurenine pathway metabolites in patients with Behçet disease.
    Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sivrikaya A; Kuzu M; Yerlikaya FH; Yilmaz S; Unlu A
    Amino Acids; 2022 Jun; 54(6):877-887. PubMed ID: 35604497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
    Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
    J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
    Ryan KM; Allers KA; McLoughlin DM; Harkin A
    Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus.
    Eryavuz Onmaz D; Tezcan D; Yilmaz S; Onmaz M; Unlu A
    Amino Acids; 2023 Dec; 55(12):1937-1947. PubMed ID: 37925676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
    Kurgan Ş; Önder C; Balcı N; Akdoğan N; Altıngöz SM; Serdar MA; Günhan M
    Clin Oral Investig; 2022 Sep; 26(9):5721-5732. PubMed ID: 35588020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review.
    Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Mohamadkhani A; Klegeris A; McElhinney A; Mafi Z; Hajiesmaeili M; Sayehmiri F
    Front Immunol; 2022; 13():1013784. PubMed ID: 36426364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of serum neopterin and calprotectin as biomarkers for subclinical inflammation in patients with familial Mediterranean fever.
    Tezcan D; Onmaz DE; Sivrikaya A; Hakbilen S; Körez MK; Gülcemal S; Yılmaz S
    Ir J Med Sci; 2023 Aug; 192(4):2015-2022. PubMed ID: 36163581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the immune-kynurenine pathway in treatment-resistant schizophrenia.
    Chen W; Tian Y; Gou M; Wang L; Tong J; Zhou Y; Feng W; Li Y; Chen S; Liu Y; Wang Z; Pan S; Zhang P; Huang J; Yang X; Li CR; Tian L; Hong LE; Tan Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110926. PubMed ID: 38147973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy.
    Wang Y; Fang X; Wang G; Tang W; Liu S; Yang Y; Chen J; Ling Y; Zhou C; Zhang X; Zhang C; Su KP
    Brain Behav Immun; 2023 Oct; 113():1-11. PubMed ID: 37353059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.
    Laugeray A; Launay JM; Callebert J; Surget A; Belzung C; Barone PR
    Behav Brain Res; 2010 Jun; 210(1):84-91. PubMed ID: 20153778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
    Fujigaki H; Yamamoto Y; Saito K
    Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
    Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Hajibeygi R; Shool S; Sodeifian F; Klegeris A; McElhinney A; Tavirani MR; Sayehmiri F
    Front Immunol; 2022; 13():997240. PubMed ID: 36263032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mediating Role of Kynurenine Pathway Metabolites on the Relationship Between Inflammation and Muscle Mass in Oldest-Old Men.
    Hetherington-Rauth M; Johnson E; Migliavacca E; Langsetmo L; Hepple RT; Ryan TE; Ferrucci L; Breuillé D; Corthesy J; Lane NE; Feige JN; Napoli N; Tramontana F; Orwoll ES; Cawthon PM
    J Gerontol A Biol Sci Med Sci; 2024 Jul; 79(7):. PubMed ID: 38761087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: The role of immune activation.
    Mechtcheriakov S; Gleissenthall GV; Geisler S; Arnhard K; Oberacher H; Schurr T; Kemmler G; Unterberger C; Fuchs D
    Alcohol Clin Exp Res; 2022 Sep; 46(9):1648-1656. PubMed ID: 35938556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress.
    Kucukkarapinar M; Yay-Pence A; Yildiz Y; Buyukkoruk M; Yaz-Aydin G; Deveci-Bulut TS; Gulbahar O; Senol E; Candansayar S
    J Neural Transm (Vienna); 2022 Aug; 129(8):1077-1089. PubMed ID: 35796878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders.
    Li Y; Wang L; Huang J; Zhang P; Zhou Y; Tong J; Chen W; Gou M; Tian B; Li W; Luo X; Tian L; Hong LE; Li CR; Tan Y
    Front Psychiatry; 2024; 15():1357293. PubMed ID: 38680780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.